VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy

V-domain Ig suppressor of T cell activation (VISTA) is a B7 family member that maintains T cell and myeloid quiescence and is a promising target for combination cancer immunotherapy. During inflammatory challenges, VISTA activity reprograms macrophages towards reduced production of proinflammatory c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Long, Tatineni, Jahnavi, Mahoney, Kathleen M., Freeman, Gordon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088836/
https://www.ncbi.nlm.nih.gov/pubmed/33495077
http://dx.doi.org/10.1016/j.it.2020.12.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088836/
https://www.ncbi.nlm.nih.gov/pubmed/33495077
http://dx.doi.org/10.1016/j.it.2020.12.008

Ejemplares similares